Document is current
Any future updates will be listed below
-
Authors
Ndum, Naomi C.
Trippler, Lydia
Najim, Sarah O.
Ali, Anisa S.
Hattendorf, Jan
Ame, Shaali M.
Kabole, Fatma
Utzinger, Jürg
Ali, Said M.
Knopp, Stefanie https://orcid.org/0000-0001-5707-7963
-
Clinical Trials BETA
Clinical trials referenced in this document:
isrctn91431493 at ISRCTN.orgDocuments that mention this clinical trial
One-year impact of behavioural interventions on schistosomiasis-related knowledge, attitude and practices of primary schoolchildren in Pemba, Tanzania
https://doi.org/10.1186/s40249-024-01251-y
Impact of chemical snail control on intermediate host snail populations for urogenital schistosomiasis elimination in Pemba, Tanzania: findings of a 3-year intervention study
https://doi.org/10.1186/s13071-024-06565-2
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PR00P3_179753 / 1)
Swiss Government Excellence Scholarships
- License Information
-
More Information
Article History
Received: 14 June 2024
Accepted: 8 October 2024
First Online: 13 November 2024
Declarations
:
: Before the onset of the SchistoBreak project in 2019, the study protocol received a waiver from the ethics committee of Switzerland (Ethikkommission Nordwest- und Zentralschweiz; EKNZ; project-ID: Req-2019–00951). The Zanzibar Health Research Institute (ZAHRI) granted ethical approval of the study protocol and this was renewed every year. The latest extension was approved in March 2023 (ZAHREC/04/AMEND/MARCH/2023/03). The study was registered at ISRCTN (ISCRCTN91431493) on 11 February 2020 (). All potential participants for this study were informed about the purpose and procedures of the study by the local research team. Upon selection, each child invited to participate in the study was provided with an information sheet detailing the study procedures and with an informed consent form (ICF) for their parents to sign. Only children who submitted an ICF signed by their parents were eligible to participate in the study. Children aged 12–17 years were additionally requested to sign an assent form for their participation. The local language Kiswahili was used for communication during information meetings, informed consent procedures and the questionnaire survey. All documents used for local application in the study were translated from English to Kiswahili with the support of the local research team and validated before use. All schoolchildren infected with <i>S. haematobium</i> were informed about their diagnostic results and offered praziquantel (40 mg/kg oral dose) for treatment at no cost.
: Not applicable.
: Jürg Utzinger is a deputy Editor-in-Chief of the journal <i>Infectious Diseases of Poverty</i>. He was not involved in the peer-review or handling of the manuscript. The authors have no other competing interests to disclose.
